The SIGA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SIGA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SIGA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SIGA Detailed Price Forecast - CNN Money||View SIGA Detailed Summary - Google Finance|
|View SIGA Detailed Summary - Yahoo! Finance||View SIGA Stock Research & Analysis - Zacks.com|
|View SIGA Trends & Analysis - Trade-Ideas||View SIGA Major Holders - Barrons|
|View SIGA Call Transcripts - NASDAQ||View SIGA Breaking News & Analysis - Seeking Alpha|
|View SIGA Annual Report - CompanySpotlight.com||View SIGA OTC Short Report - OTCShortReport.com|
|View SIGA Fundamentals - TradeKing||View SIGA SEC Filings - Bar Chart|
|View Historical Prices for SIGA - The WSJ||View Performance/Total Return for SIGA - Morningstar|
|View the Analyst Estimates for SIGA - MarketWatch||View the Earnings History for SIGA - CNBC|
|View the SIGA Earnings - StockMarketWatch||View SIGA Buy or Sell Recommendations - MacroAxis|
|View the SIGA Bullish Patterns - American Bulls||View SIGA Short Pain Metrics - ShortPainBot.com|
|View SIGA Stock Mentions - StockTwits||View SIGA Stock Mentions - PennyStockTweets|
|View SIGA Stock Mentions - Twitter||View SIGA Investment Forum News - Investor Hub|
|View SIGA Stock Mentions - Yahoo! Message Board||View SIGA Stock Mentions - Seeking Alpha|
|View Insider Transactions for SIGA - SECform4.com||View Insider Transactions for SIGA - Insider Cow|
|View SIGA Major Holdings Summary - CNBC||View Insider Disclosure for SIGA - OTC Markets|
|View Insider Transactions for SIGA - Yahoo! Finance||View Institutional Holdings for SIGA - NASDAQ|
|View SIGA Stock Insight & Charts - FinViz.com||View SIGA Investment Charts - StockCharts.com|
|View SIGA Stock Overview & Charts - BarChart||View SIGA User Generated Charts - Trading View|
Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss
Posted on Thursday May 03, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks ( Stocks hitting 52-week highs on May 2 ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Eleven Biotherapeutics ...
Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings
Posted on Wednesday May 02, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 1) ABIOMED, Inc. (NASDAQ: ABMD ) AveXis Inc (NASDAQ: AVXS ) (announced ...
SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®
Posted on Tuesday May 01, 2018
SIGA Technologies, Inc. (SIGA) (SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee meeting on oral TPOXX®, a small molecule antiviral treatment for smallpox. The panel, comprised of independent medical experts, voted unanimously, 17 to 0, that the benefits of TPOXX outweigh its risks. “We are pleased that the advisory panel believes strongly in the benefits of TPOXX.
SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX®
Posted on Tuesday May 01, 2018
The panel, comprised of independent medical experts, will consider whether the benefits of TPOXX outweigh its risks. The FDA has previously announced that its target final action date for the oral TPOXX NDA is August 8, 2018.